Deciphera Pharmaceuticals, Inc. (DCPH)
42.79 0.00 (0.00%)
After hours: 4:19PM EST
| Previous close | 42.96 |
| Open | 42.96 |
| Bid | 42.67 x 800 |
| Ask | 42.87 x 1200 |
| Day's range | 40.35 - 43.14 |
| 52-week range | 33.10 - 68.40 |
| Volume | 539,301 |
| Avg. volume | 448,273 |
| Market cap | 2.466B |
| Beta (5Y monthly) | 1.53 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.78 |
| Earnings date | 03 May 2021 - 07 May 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 75.00 |
- Business Wire
Deciphera Pharmaceuticals, Inc. to Present at the Barclays Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference on March 9, 2021 at 1:50 PM ET. The conference will be held in a virtual meeting format.
- Business Wire
Deciphera Pharmaceuticals, Inc. to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a fireside chat at the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021 at 4:20 PM ET. The conference will be held in a virtual meeting format.
- Simply Wall St.
Broker Revenue Forecasts For Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) Are Surging Higher
Deciphera Pharmaceuticals, Inc. ( NASDAQ:DCPH ) shareholders will have a reason to smile today, with the analysts...
